Swiss National Bank Sells 51,300 Shares of Intuitive Surgical, Inc. $ISRG

Swiss National Bank lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,033,200 shares of the medical equipment provider’s stock after selling 51,300 shares during the period. Swiss National Bank’s holdings in Intuitive Surgical were worth $462,078,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. Tobam increased its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the period. Kilter Group LLC bought a new stake in Intuitive Surgical during the second quarter worth about $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in Intuitive Surgical during the third quarter worth about $27,000. Caitlin John LLC acquired a new stake in Intuitive Surgical during the third quarter worth about $30,000. Finally, Guerra Advisors Inc bought a new position in Intuitive Surgical in the 3rd quarter valued at about $37,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of the company’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the completion of the transaction, the director directly owned 3,694 shares of the company’s stock, valued at $1,958,189.40. This represents a 86.90% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 37,261 shares of company stock worth $19,690,721 in the last 90 days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $490.16 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The firm has a market capitalization of $174.07 billion, a P/E ratio of 62.12, a P/E/G ratio of 3.78 and a beta of 1.66. The company’s 50 day moving average price is $521.64 and its two-hundred day moving average price is $512.51.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the prior year, the business earned $2.21 earnings per share. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent analyst reports. Truist Financial upped their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. UBS Group set a $570.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Tuesday, February 24th. Royal Bank Of Canada raised their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Sanford C. Bernstein lifted their price target on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Finally, TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Two analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $615.86.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.